Reference method for detection of Pgp mediated multidrug resistance in human hematological malignancies: A method validated by the laboratories of the French drug resistance network

Communications in Clinical Cytometry

Volumn 34, Issue 6, 1998, Pages 248-256

  Huet, Sylvie ^a,b   Marie, Jean Pierre ^a   Gualde, Norbert ^b   Robert, Jacques ^c  

^a Laboratoire d'Immunologie et Immunogénétique HÔpital Pellegrin   (France)

^b INSTITUT BERGONIÉ   (France)

^c HÔTEL DIEU   (France)

Author keywords

Flow cytometry; MRK16; P glycoprotein; Rhodamine 123; UIC2

Indexed keywords

GLYCOPROTEIN P; RHODAMINE 123;

ACTIVE TRANSPORT; ACUTE LEUKEMIA; ANALYTIC METHOD; ARTICLE; BLOOD DISEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LABORATORY TEST; MULTIDRUG RESISTANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REFERENCE VALUE; REPRODUCIBILITY; TECHNIQUE; VALIDATION PROCESS;

CELL LINE; DRUG RESISTANCE, MULTIPLE; EVALUATION STUDIES; FLOW CYTOMETRY; HEMATOLOGIC NEOPLASMS; HUMANS; P-GLYCOPROTEIN; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; RHODAMINE 123;

EID: 0032534883     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19981215)34:6<248::AID-CYTO2>3.0.CO;2-X     Document Type: Article

References (14)

1. Beck WT, Grogan TM, Willman CL, Cordoncardo C, Parham DM, Kuttesch JF, AndreeffM, Bates SE, Berard CW, Boyett JM, Brophy NA, Broxtennan HJ, Chan HSL, Dalton WS, Dietel M, Fojo AT, Gascoyne RD, Head D, Hougliton PJ, Srivastaa DK, Lehnen M, Leith CP, Paietta E, Pavelic ZP, Rimsza L, Roninson IB, Sikic BI, Twentyman PR, Warnke R, Weinstein R. Methods to detect P-glycoprotein-associated multidrug resistance in patients tumors: consensus recommendations. Cancer Res 56: 3010-3020, 1996.
2. Chevillard S, Vielh P, Validire P, Marie JP, Faussât AM, Barbu V, Bayle C, Benard J, Bonnal C, Boutonnât J, Calvo F, Charrier J, Clary A, Colosetti P, Danel-Moore L, Decremoux P, Delvincourt C, FinatDuclos F, Genne P, Kataki A, Kouyoumdjian JC, Lacave R, Maugard C, Merlin JL, Mousseau M, Pinguet-F, Quillien V, Raphael M, Richard B, Verrelle P, Robert J. French multicentric evaluation of mdrl gene expression by RT-PCR in leukemia and solid tumours. Standardization of RT-PCR and preliminary comparisons between RT-PCR and immunohistochemistry in solid tumours. Leukemia 11: 1095-1106,1997.
3. Fenneteau O, Marie JP, Lescoeur B, Vilmer E, Schlegel N. Expression of the multidrug resistance-associated P-glycoprotein (p-170) in acute lymphoblastic leukemia. Blood 82: 3787-3788, 1993.
4. Georges E, Sharom FJ, Ling V. Multidrug resistance and chemosensitization. Therapeutic implications for cancer chemotherapy. Adv Pharmacol21: 185-220, 1990.
5. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427, 1993.
6. Gruber A, Vitols S, Norgren S, Arestrom I, Peterson C, Bjorkholm M, Reizenstein P, Luthman H. Quantitative determination of mdrl gene expression in leukaemic cells from patients with acute leukaemia. Br J Cancer 66: 266-272,1992.
7. Huet S, Chapey C, Robert J. Reversal of Multidrug resistance by a new lipophilic cationic molecule S9788. Comparison with 11 other MDRmodulating agents in a model of doxorubicin-resistant rat glioblastoma cells. EurJ Cancer 29: 1377-1383,1993.
8. Ito Y, Tanimoto M, Kumazawa T, Okumura M, Morishima Y, Ohno R, Saito H. Increased P-glycoprotein expression and multidrug-resistant gene (mdrl) amplification are infrequently found in fresh acute leukemia cells. Cancer 63: 1534-1538, 1989.
9. Krishan A, Fitz CM, Andritsch I. Drug retention, efflux, and resistance in tumor cells. Cytometry 29: 279-285,1997.
10. Krishan A, Sauerteig A, Andritsch I, Welham L. Flow cytometric analysis of the multiple drug resistance phenotype. Leukemia 11: 1138-1146, 1997.
11. Marie JP. P-glycoprotein in adult hématologie malignancies. Hematol Oncol Clin N Amer 9: 239-249,1995.
12. Marie JP, Huet S, Faussât AM, Perrot JY, Chevillard S, Barbu V, Bayle C, Boutonnât J, Calvo F, Campos-Guyotat L, Colosetti P, Cazin JL, de Cremoux P, Delvincourt C, Demur C, Drenou B, Fenneteau O, Feuillard J, Gamier-Suillerot A, Genne P, Gorisse MC, Gosselin P, Jouault H, Lacave R, Le Calvez G, Leglise MC, Léonce S, Manfait M, Maynadie M, Merle-Beral H, Mousseau M, Morjani II, Picard F, Pinguet F, Poncelet P, Racadot E, Raphaël M, Richard B, Rossi JF, Schlegel N, Viehl P, Zhou DC, Robert J. Multicentric evaluation of the MDR phenotype in leukemia. Leukemia 11: 1086-1094,1997.
13. Zhou DC, Marie JP, Suberville AM, Zittoun R. Relevance of mdrl gene expression in acute myeloid leukemia and comparison of different diagnostic methods. Leukemia 6:879-885,1992.
14. Zhou DC, Ramond S, Vignie F, Faussât AM, Zittoun R, Marie JP. Progressive resistance to homoharringtonine in human myeloleukemia K562 cells: relationship to sequential gene translation. Int J Cancer65: 365-371,1996.